Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score

Gut

Volumn 54, Issue 8, 2005, Pages 1174-1179

  Forrest, E H ^a,b   Evans, C D J ^a   Stewart, S ^c   Phillips, M ^d   Oo, Y H ^e   McAvoy, N C ^f   Fisher, N C ^g   Singhal, S ^h   Brind, A ⁱ   Haydon, G ^e   O'Grady, J ^d   Day, C P ^c   Hayes, P C ^f   Murray, L S ^j   Morris, A J ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b VICTORIA INFIRMARY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d KING S COLLEGE HOSPITAL   (United Kingdom)

^e UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^f ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^g CITY HOSPITAL   (United Kingdom)

^h SANDWELL GENERAL HOSPITAL   (United Kingdom)

ⁱ University Hospital   (United Kingdom)

^j WESTERN INFIRMARY   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; UREA;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BILIRUBIN BLOOD LEVEL; FEMALE; GLASGOW COMA SCALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROTHROMBIN TIME; UREA BLOOD LEVEL;

BILIRUBIN; BLOOD CELL COUNT; HEPATITIS, ALCOHOLIC; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTHROMBIN TIME; REPRODUCIBILITY OF RESULTS; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; UREA;

EID: 22644432242     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.050781     Document Type: Article

References (15)

1. Maddrey WC, Boitnott JK, Bedine MS, et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978;75:193-9.
2. Carithers JRL, Herlong HF, Diehl AM, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis: a randomized multicenter trial. Ann Intern Med 1989;110:685-90.
3. Mathurin P, Mendenhall CL, Carithers J, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 2002;36:480-7.
4. McCullough AJ, O'Connor JFB. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998;93:2022-36.
5. Sheth M, Riggs M, Patel T. Utility of the Mayo end-stage liver disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2002;2:2.
6. Kumashiro R, Sata M, Ishii K, et al. Prognostic factors for short-term survival in alcoholic hepatitis in Japan: analysis by logistic regression. Alcoholism. Clin Exp Res 1996;20(suppl 9):383-6A.
7. Lolekha PH, Sritong N. Comparison of techniques for minimizing interference of bilirubin on serum creatinine determined by the kinetic Jaffe reaction. J Clin Lab Anal 1994;8:391-9.
8. Newsome PN, Henderson NC, Germain L, et al. Prothrombin time to assess fulminant hepatic failure. Lancet 2001;358:2172.
9. Depew W, Boyer T, Omata M, et al. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology 1980;78:524-9.
10. Theodossi A, Eddleston ALWF, Williams R. Controlled trial of methylprednisolone therapy in severe alcoholic hepatitis. Gut 1982;23:75-9.
11. Mendenhall CL, Anderson S, Garcia-Pont P, et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxdandrolone and prednisolone. N Engl J Med 1984;311:1464-70.
12. Akriviadis E, Botla R, Briggs W, et al. Pentoxifylline improves short term survival in severe alcoholic hepatitis: a double blind placebo controlled trial. Gastroenterology 2000;119:1637-48.
13. Ramond MJ, Poynard T, Rueff B, et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992;326:507-12.
14. Castera L, Hartmann DJ, Chapel F, et al. Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis. J Hepatol 2000;32:412-8.
15. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40:897-903.